Background: Drug delivery mucoadhesion has been a subject of study for decades,
initially focusing on understanding processes and investigating polymers.
Mucoadhesive tablets are oral dosage forms that adhere to mucosal surfaces,
promoting prolonged contact and localized drug delivery. Aim and Objective: A
mucoadhesive tablet formulation of metformin could enhance drug delivery and
improve therapeutic outcomes for patients with type 2 diabetes. Material and
Method: The wet granulation process is used to develop mucoadhesive tablets by
developing granules with the ideal characteristics for compression and tablet
production. The process involves the use of natural mucoadhesive polymers like
pectin and xanthan gum, along with the active component of metformin. Various
testing techniques, such as weight variation, friability, hardness, DSC, TGA,
XRD, in vitro dissolution, and release kinetics, are used to evaluate
mucoadhesive tablets. Result and Discussion: Most formulations exhibited optimal
test results within official limits in terms of friability, weight variation, and
hardness. Thermal analysis indicated a transition within the temperature range,
showed an exothermic peak in DSC analysis, and demonstrated temperature
stability in thermogravimetric analysis. In vitro dissolution studies revealed
exceptional drug release, reaching approximately 101% over 12 hours. The
release kinetics modeling, performed through regression analysis, indicated
sustained release. The n-exponent of the Korsmeyer and Peppas models
suggested Fickian drug release. Conclusion: The successfully synthesized
mucoadhesive tablets, formulated with natural and biocompatible mucoadhesive
polymers, exhibit optimal drug release properties. They are utilized for prolonged drug release for up to 12 hours, aiding in diabetic management through metformin.
Keywords: Natural polymers, mucoadhesion, Metformin, diabetes type-II, sustained release
